Has Stanley Crawford, DO received payments from drug or device companies?

Yes. Drug and device makers reported $16,194 in general payments to Stanley Crawford, DO across 185 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stanley Crawford, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stanley Crawford, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stanley Crawford, DO

Orthopaedic Surgery of the Spine · Monroe, LANPI 1497171888

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (49.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Globus Medical at 49.0% of the total. 2025 is the largest year on record at $8,430, 3.6 times the $2,347 reported in 2020.

$16,194in general payments, 2019–2025

Across 185 payments — averaging $87.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Globus Medical$8K
Heron Therapeutics, Inc.$3K
Cerapedics Inc.$2K
Stryker$1K
Midsouth Orthopedics Inc.$537
Boston Scientific$416
plus $1K from 15 others

What the payments were for

Consulting fees$2,80017%
Travel & lodging$8,02650%
Food & beverage$5,26933%
Education$991%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Globus Medical	97	$7,928
Heron Therapeutics, Inc.	3	$2,800
Cerapedics Inc.	8	$2,338
Stryker	33	$1,003
Midsouth Orthopedics Inc.	2	$537
Boston Scientific	16	$416
Arthrex	3	$208
Curonix LLC	1	$181
Siemens Medical Solutions USA, Inc.	3	$150
Si-bone, Inc.	2	$143
Orthofix Medical, Inc.	1	$92
Providence Medical Technology, Inc.	2	$69
Misonix Inc	2	$66
Amgen	2	$52
Johnson & Johnson	2	$49
AbbVie	2	$38
Kerecis Limited	1	$36
Centinel Spine, LLC	1	$36
Pfizer	2	$24
Spineology Inc.	1	$16
Pacira Therapeutics, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Zynrelef$2,800
I-FACTOR PEPTIDE ENHANCED BONE GRAFT$2,199
Excelsius Robotics System$1,356
ELSA, ELSA AL/ATP$1,138
Spine$783
INDEPENDENCE$351
RISE-L$226
PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$181
TLIF$169
CREO$149
VARIAX$107
T2$107
ACUSON Sequoia Diagnostic Ultrasound System$104
GENERAL PAIN MANAGEMENT$103
Excelsius - GPS$100

How this compares

$16,194 in reported general payments places this provider in the 60th percentile of 29 orthopaedic surgery of the spine providers in Louisiana.

See all orthopaedic surgery of the spine providers in Louisiana →

Medicare billing

Part B allowed, 2024

$447,511

Medicare patients

683

Services billed

4,845

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	220	$1,511
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	191	$1,188
Meloxicam	319	$951
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	91	$850
Pregabalin	28	$432
Tizanidine Hcl	89	$423
Celecoxib	22	$365
Diclofenac Sodium	32	$357
Tramadol Hcl	147	$335
Ibuprofen	22	$148
Methylprednisolone	22	$119
Naproxen	13	$111
Ciprofloxacin Hcl	20	$73
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	17	$72
Duloxetine Hcl	11	$70

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Monroe

Andrew MeyersMonroe$9K
Mathew CyriacNew Orleans$368K
Joseph ZavatskyMetairie$205K
Lon BaronneLafayette$190K
Alexis WaguespackMetairie$63K
Charles YuNew Orleans$52K
Stephen HogeShreveport$48K
William AccoustiNew Orleans$46K
Amit BhandutiaNew Orleans$39K
Milan ModyShreveport$33K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →